Gene: PLEKHA3
Official Full Name: pleckstrin homology domain containing A3provided by HGNC
Gene Summary: Enables identical protein binding activity and phosphatidylinositol-4-phosphate binding activity. Predicted to be involved in endosome organization; receptor recycling; and retrograde transport, endosome to Golgi. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15079 | PLEKHA3 Knockout cell line (HeLa) | Human | PLEKHA3 | 1:3~1:6 | Negative | Online Inquiry |
KO15080 | PLEKHA3 Knockout cell line (HCT 116) | Human | PLEKHA3 | 1:2~1:4 | Negative | Online Inquiry |
KO15081 | PLEKHA3 Knockout cell line (HEK293) | Human | PLEKHA3 | 1:3~1:6 | Negative | Online Inquiry |
KO15082 | PLEKHA3 Knockout cell line (A549) | Human | PLEKHA3 | 1:3~1:4 | Negative | Online Inquiry |
PLEKHA3 Gene Knockout Cell Lines are genetically engineered cell lines wherein the PLEKHA3 gene has been specifically inactivated or "knocked out." This process utilizes cutting-edge CRISPR-Cas9 technology, which enables precise editing of the genome. The PLEKHA3 gene encodes a pleckstrin homology domain-containing protein that plays a crucial role in cell signaling, cytoskeletal organization, and various physiological processes. By eliminating the function of this gene, researchers can investigate its role in cellular mechanisms, disease progression, and therapeutic potential, thereby expanding the understanding of complex biological pathways.
The principal function of these knockout cell lines is to serve as an invaluable tool for elucidating the biological role of PLEKHA3 in both normal and pathological states. By comparing PLEKHA3-deficient cells to wild-type controls, scientists can study aberrations in cellular signaling, migration, proliferation, and metabolism. This is particularly relevant in research areas such as cancer biology, where PLEKHA3 may influence tumor growth and metastasis.
The scientific significance of PLEKHA3 Gene Knockout Cell Lines lies in their ability to facilitate functional genomics and provide insights into gene function that can translate into clinical applications. These cell lines are pivotal in drug development processes, allowing for screening and validation of therapeutic targets related to PLEKHA3-associated conditions. Furthermore, they can act as models for studying disease mechanisms, ultimately contributing to advancements in personalized medicine.
Compared to traditional cell lines that retain the PLEKHA3 gene, these knockout cell lines provide researchers with an unparalleled opportunity to characterize gene-specific effects more accurately. This specificity enhances the reliability of experimental outcomes and provides a clearer understanding of the gene's role within diverse biological contexts.
For researchers and clinicians dedicated to unraveling the complexities of cell signaling and disease pathology, PLEKHA3 Gene Knockout Cell Lines offer a unique and powerful approach to accelerate scientific discovery. By choosing our product, you are tapping into our company’s extensive expertise in genetic engineering and cellular biology, ensuring that you receive high-quality, validated models that meet the rigorous demands of modern research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.